Su Young Chae

3.9k total citations
55 papers, 3.1k citations indexed

About

Su Young Chae is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Su Young Chae has authored 55 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 18 papers in Endocrinology, Diabetes and Metabolism and 15 papers in Surgery. Recurrent topics in Su Young Chae's work include RNA Interference and Gene Delivery (20 papers), Pancreatic function and diabetes (15 papers) and Advanced biosensing and bioanalysis techniques (12 papers). Su Young Chae is often cited by papers focused on RNA Interference and Gene Delivery (20 papers), Pancreatic function and diabetes (15 papers) and Advanced biosensing and bioanalysis techniques (12 papers). Su Young Chae collaborates with scholars based in South Korea, United States and Australia. Su Young Chae's co-authors include Jae‐Woon Nah, Mi-Kyeong Jang, Sung Wan Kim, Cheol-Hee Ahn, Seulki Lee, Sohee Son, Yu Seok Youn, You Han Bae, You Han Bae and Minhyung Lee and has published in prestigious journals such as Nature Communications, Biomaterials and The Journal of Physical Chemistry B.

In The Last Decade

Su Young Chae

55 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Su Young Chae South Korea 33 1.4k 982 663 434 417 55 3.1k
Kang Choon Lee South Korea 31 1.3k 0.9× 925 0.9× 557 0.8× 240 0.6× 297 0.7× 55 2.7k
Xia Zhao China 36 1.8k 1.3× 701 0.7× 250 0.4× 327 0.8× 79 0.2× 118 4.1k
Qinjie Wu China 37 1.5k 1.1× 1.5k 1.5× 348 0.5× 805 1.9× 63 0.2× 92 4.2k
Zengshuan Ma Canada 19 784 0.6× 668 0.7× 641 1.0× 347 0.8× 79 0.2× 23 2.1k
Yong‐Hee Kim South Korea 33 2.0k 1.5× 916 0.9× 480 0.7× 179 0.4× 37 0.1× 102 3.4k
Deepak Chitkara India 29 1.4k 1.0× 755 0.8× 395 0.6× 109 0.3× 112 0.3× 87 2.7k
Hiroaki Okada Japan 22 609 0.4× 599 0.6× 888 1.3× 140 0.3× 124 0.3× 26 2.0k
Peng‐Hui Wang China 32 843 0.6× 737 0.8× 94 0.1× 303 0.7× 124 0.3× 103 3.2k
Taishi Higashi Japan 30 1.3k 1.0× 700 0.7× 484 0.7× 172 0.4× 54 0.1× 155 2.9k
Anna Mero Italy 25 1.3k 0.9× 849 0.9× 241 0.4× 166 0.4× 57 0.1× 34 2.8k

Countries citing papers authored by Su Young Chae

Since Specialization
Citations

This map shows the geographic impact of Su Young Chae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Young Chae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Young Chae more than expected).

Fields of papers citing papers by Su Young Chae

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Young Chae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Young Chae. The network helps show where Su Young Chae may publish in the future.

Co-authorship network of co-authors of Su Young Chae

This figure shows the co-authorship network connecting the top 25 collaborators of Su Young Chae. A scholar is included among the top collaborators of Su Young Chae based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Young Chae. Su Young Chae is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Son, Sohee, Sung Mook Lim, Su Young Chae, et al.. (2015). Mono-lithocholated exendin-4-loaded glycol chitosan nanoparticles with prolonged antidiabetic effects. International Journal of Pharmaceutics. 495(1). 81–86. 12 indexed citations
2.
Lee, Jung‐Hoon, Jung‐Min Lee, Jung‐Min Kim, et al.. (2014). Protein grafting of p53TAD onto a leucine zipper scaffold generates a potent HDM dual inhibitor. Nature Communications. 5(1). 3814–3814. 9 indexed citations
3.
Park, Jong Sung, Seol-Hee Kim, Kwangmeyung Kim, et al.. (2013). Inhibition of Notch signalling ameliorates experimental inflammatory arthritis. Annals of the Rheumatic Diseases. 74(1). 267–274. 72 indexed citations
4.
Yun, Ui Jeong, Min Sang Lee, Sohee Son, et al.. (2012). Cell-penetrating peptide mimicking polymer-based combined delivery of paclitaxel and siRNA for enhanced tumor growth suppression. International Journal of Pharmaceutics. 434(1-2). 488–493. 39 indexed citations
5.
Chae, Su Young, Min Sang Lee, Yuhan Lee, et al.. (2011). Energy‐Independent Intracellular Gene Delivery Mediated by Polymeric Biomimetics of Cell‐Penetrating Peptides. Macromolecular Bioscience. 11(9). 1169–1174. 39 indexed citations
6.
Chae, Su Young, Tae Hyung Kim, Kyeongsoon Park, et al.. (2010). Improved Antitumor Activity and Tumor Targeting of NH2-Terminal–Specific PEGylated Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand. Molecular Cancer Therapeutics. 9(6). 1719–1729. 64 indexed citations
7.
Chae, Su Young, et al.. (2010). The fatty acid conjugated exendin-4 analogs for type 2 antidiabetic therapeutics. Journal of Controlled Release. 144(1). 10–16. 72 indexed citations
8.
Oh, Eun Ju, et al.. (2010). Long acting hyaluronate – exendin 4 conjugate for the treatment of type 2 diabetes. Biomaterials. 31(14). 4121–4128. 73 indexed citations
9.
Chae, Su Young, Cheng‐Hao Jin, Jae Hee Shin, et al.. (2009). Biochemical, pharmaceutical and therapeutic properties of long-acting lithocholic acid derivatized exendin-4 analogs. Journal of Controlled Release. 142(2). 206–213. 57 indexed citations
10.
Chae, Su Young, et al.. (2008). Intrapulmonary potential of polyethylene glycol-modified glucagon-like peptide-1s as a type 2 anti-diabetic agent. Regulatory Peptides. 152(1-3). 101–107. 37 indexed citations
11.
Chae, Su Young, Seulki Lee, Kyeongsoon Park, et al.. (2008). Stability and bioactivity of nanocomplex of TNF-related apoptosis-inducing ligand. International Journal of Pharmaceutics. 363(1-2). 149–154. 30 indexed citations
12.
Chae, Su Young, et al.. (2008). Pharmacokinetic and pharmacodynamic evaluation of site-specific PEGylated glucagon-like peptide-1 analogs as flexible postprandial-glucose controllers. Journal of Pharmaceutical Sciences. 98(4). 1556–1567. 32 indexed citations
13.
Youn, Yu Seok, et al.. (2007). Improved intrapulmonary delivery of site-specific PEGylated salmon calcitonin: Optimization by PEG size selection. Journal of Controlled Release. 125(1). 68–75. 61 indexed citations
14.
15.
Kim, Yong Yeon, Su Young Chae, Sung‐Won Kim, Youngro Byun, & You Han Bae. (2005). Improved phenotype of rat islets in a macrocapsule by co-encapsulation with cross-linked Hb. Journal of Biomaterials Science Polymer Edition. 16(12). 1521–1535. 7 indexed citations
16.
Chae, Su Young, Sohee Son, Minhyung Lee, Mi-Kyeong Jang, & Jae‐Woon Nah. (2005). Deoxycholic acid-conjugated chitosan oligosaccharide nanoparticles for efficient gene carrier. Journal of Controlled Release. 109(1-3). 330–344. 152 indexed citations
17.
Ahn, Cheol-Hee, Su Young Chae, You Han Bae, & Sung Wan Kim. (2004). Synthesis of biodegradable multi-block copolymers of poly(l-lysine) and poly(ethylene glycol) as a non-viral gene carrier. Journal of Controlled Release. 97(3). 567–574. 84 indexed citations
18.
Chae, Su Young, et al.. (2003). Protection of insulin secreting cells from nitric oxide induced cellular damage by crosslinked hemoglobin. Biomaterials. 25(5). 843–850. 98 indexed citations
19.
Ahn, Cheol-Hee, Su Young Chae, You Han Bae, & Sung Wan Kim. (2002). Biodegradable poly(ethylenimine) for plasmid DNA delivery. Journal of Controlled Release. 80(1-3). 273–282. 241 indexed citations
20.
Chae, Su Young, Sung Wan Kim, & You Han Bae. (2001). Bioactive Polymers for Biohybrid Artificial Pancreas. Journal of drug targeting. 9(6). 473–484. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kang Choon Lee Breakdown of academic impact, for papers by Xia Zhao Breakdown of academic impact, for papers by Qinjie Wu Breakdown of academic impact, for papers by Zengshuan Ma Breakdown of academic impact, for papers by Yong‐Hee Kim Breakdown of academic impact, for papers by Deepak Chitkara Breakdown of academic impact, for papers by Hiroaki Okada Breakdown of academic impact, for papers by Peng‐Hui Wang Breakdown of academic impact, for papers by Taishi Higashi Breakdown of academic impact, for papers by Anna Mero
Rankless by CCL
2026